|
|
Volumn 98, Issue 18, 1998, Pages 1829-1830
|
|
Safety and effectiveness of inhaled nitric oxide and tirofiban for acute coronary syndromes: A report from the cardiovascular and renal advisory panel of the food and drug administration
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
HEPARIN;
NITRIC OXIDE;
TIROFIBAN;
ADOLESCENT;
ANGIOCARDIOGRAPHY;
BLEEDING;
CHILD;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DRUG EFFICACY;
DRUG SAFETY;
EXTRACORPOREAL OXYGENATION;
HEART MUSCLE ISCHEMIA;
HUMAN;
LUNG DYSPLASIA;
MORTALITY;
NEUROLOGIC DISEASE;
NEWBORN;
NOTE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
|
|
EID: 0032480788
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.98.18.1829 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
